Reactive oxygen species in redox cancer therapy

Area of Science:

• Oncology
• Biochemistry
• Cell Biology

Background:

• Reactive oxygen species (ROS) are increasingly recognized for their significant role in cancer development, metastasis, progression, and survival.
• Cancer cells typically exhibit higher basal ROS levels compared to normal cells, highlighting a critical metabolic difference.
• Existing therapeutic strategies targeting intracellular ROS have produced variable outcomes, indicating a need for further investigation.

Purpose of the Study:

• To review the intricate production and scavenging systems of ROS within cells.
• To elucidate the dual beneficial and detrimental roles of ROS in the context of cancer cells.
• To critically examine the efficacy of antioxidants in cancer treatment, including combination therapies and potential adverse effects of excessive intake.

Main Methods:

• Literature review of studies on ROS production and scavenging mechanisms.
• Analysis of research on the role of ROS in cancer cell biology.
• Evaluation of clinical and preclinical data on antioxidant use in cancer therapy.

Main Results:

• ROS are integral to cancer cell proliferation and survival, but their specific roles can be context-dependent.
• Antioxidants show potential in cancer treatment due to their ROS-scavenging and anti-cancer properties.
• Excessive antioxidant consumption can lead to adverse health effects and potentially interfere with cancer therapies.

Conclusions:

• Understanding the complex role of ROS in cancer is crucial for developing effective therapeutic strategies.
• Antioxidants hold promise for cancer treatment but require cautious application to avoid detrimental side effects.
• Further research is needed to optimize the use of antioxidants in conjunction with conventional cancer therapies.